SCHEMBL6713346

SCHEMBL6713346

CCOC(=O)C(Cc1ccc(OCc2ccccc2)cc1)n1cccc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
PPARA Q07869 6/20 0.57
PPARG P37231 5/20 0.57
PPARD Q03181 2/20 0.57
NPSR1 Q6W5P4 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ALOX5 P09917 2/20 0.52
LTA4H P09960 2/20 0.51
NR1H4 Q96RI1 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 1/20 0.50
LAP3 P28838 1/20 0.50
MAOB P27338 1/20 0.49
FFAR1 O14842 1/20 0.49
FFAR4 Q5NUL3 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713412 0.83 PTGS2 (0.50) PPARGNPSR1HSD17B10KMT2A
SCHEMBL9493387 0.82 L3MBTL1 (0.67) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL27385612 0.81 LMNA (0.65) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL5375675 0.81 L3MBTL1 (0.65) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL4756342 0.81 L3MBTL1 (0.65) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL1596779 0.81 L3MBTL1 (0.65) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL7492211 0.80 L3MBTL1 (0.64) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL6713179 0.80 LMNA (0.64) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL7501342 0.80 LMNA (0.64) LMNAL3MBTL1PPARAPPARGPPARD
SCHEMBL4758109 0.79 PPARA (0.75) LMNAL3MBTL1PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
EP-0916651-B1 PHENYLALKYLCARBOXYLIC ACID DERIVATIVES SANKYO CO (JP) 2003-10-15 EP disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
CN-1280561-A Amidocarboxylic acid derivatives SANKYO CO (JP) 2001-01-17 CN disclosed
US-6103907-A ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT SANKYO COMPANY, LIMITED (JP) 2000-08-15 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed
CN-1219927-A Phenylalkylcarboxylic acid derivatives SANKYO CO (JP) 1999-06-16 CN disclosed
EP-0916651-A1 PHENYLALKYLCARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 1999-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 LMNA 4239/4885L3MBTL1 1431/4885PPARA 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.